FDA issues tougher warning on MRI dye tied to brain effects

December 19, 2017 by Amy Norton And E.j. Mundell, Healthday Reporters

(HealthDay)—The U.S. Food and Drug Administration on Tuesday called for tougher warnings and "additional research" into a dye commonly used with standard MRIs.

The dye—a "contrast agent"—contains a metal called gadolinium. It made news recently after claims from actor Chuck Norris that its use during MRI scans seriously affected his wife's brain.

Contrast agents are injected into the body during an MRI scan to enhance image quality.

In November, Norris and his wife, Gena, filed a lawsuit against several medical companies alleging she fell ill after exposure to gadolinium during MRI scans.

The suit said Gena Norris was left weak, tired and suffering bouts of pain and burning sensations.

After reviewing available data, the FDA on Tuesday recommended that radiologists consider how much gadolinium might be left behind in a patient's body when selecting a gadolinium-based contrast agent [GBCA] for an MRI.

The recommendation is especially important "for patients who may be at higher risk, such as those who may require repeat GBCA MRI scans to monitor a chronic condition," explained Dr. Janet Woodcock, director of the agency's Center for Drug Evaluation and Research.

Patients who are sent for an MRI should also now receive a medication guide outlining issues surrounding gadolinium, Woodcock added.

But for most patients, "gadolinium retention has not been directly linked to adverse health effects," the FDA stressed in an agency news release. It also said "the benefit of all approved GBCAs continues to outweigh any potential risks."

For now, the FDA says gadolinium agents have only one known health risk: A "small subgroup" of kidney failure patients has developed a rare skin condition that causes a painful thickening of the skin.

But gadolinium can linger in the body "for months or years after receiving the drug," the agency said, noting more research is warranted. It is asking manufacturers of GBCAs to "also conduct human and animal studies to further assess the safety of these ."

This is not the agency's first warning on gadolinium. In September, an FDA panel called for a warning to be added to the agents' labels. The warning specifies that trace amounts of gadolinium may be retained in various organs, including the skin, bone and brain.

The big question remains, though: What, if any, are the harms?

Doctors have used gadolinium-based agents for 30 years—totaling more than 300 million doses, said Dr. Vikas Gulani. He's an associate professor of radiology at Case Western Reserve University in Cleveland.

But, Gulani explained, researchers have only recently discovered that trace amounts of the metal can be left behind in the brain.

One study on the issue was presented Nov. 29 at the annual meeting of the Radiological Society of North America.

It involved nearly 4,300 older adults and found no evidence that gadolinium exposure was related to faster mental decline over several years, according to a team led by Dr. Robert McDonald, of the Mayo Clinic in Rochester, Minn.

"This study provides useful data that at the reasonable doses 95 percent of the population is likely to receive in their lifetime, there is no evidence at this point that gadolinium retention in the brain is associated with adverse clinical outcomes," McDonald said in a news release from the meeting.

So, "at this point," Gulani said, "we are not aware of any harms from these agents being retained in the brain."

Still, he added, the latest study does not rule out that possibility. There are open questions—including whether gadolinium exposure could be related to other neurological issues, such as movement problems.

Also, any theoretical risks from the agents have to be balanced against their proven benefit in improving MRI image quality.

However, there are cases where an MRI can be done without a contrast agent, Gulani said. "It's reasonable for patients to ask their doctor whether it's needed or not," he added.

Gulani helped craft the latest recommendations from the International Society of Magnetic Resonance in Medicine on using MRI contrast agents. They say that if a -based agent is not necessary, it should be skipped.

"It's just like with any other medication," Gulani said. "If you don't need it, don't use it."

Explore further: Chuck Norris says MRI dye harmed wife's brain, but study finds no link

More information: U.S. Food and Drug Administration, news release, Dec. 19, 2017; Vikas Gulani, M.D., Ph.D., associate professor, radiology, Case Western Reserve University, Cleveland; Nov. 29, 2017, presentation, Radiological Society of North America annual meeting, Chicago

The U.S. Food and Drug Administration has more on gadolinium-based contrast agents.

Related Stories

Chuck Norris says MRI dye harmed wife's brain, but study finds no link

November 29, 2017
(HealthDay)—Despite recent claims from actor Chuck Norris that a dye commonly used during MRI scans seriously sickened his wife, a new study finds no evidence to support such a link.

Study finds no evidence that gadolinium causes neurologic harm

November 29, 2017
There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive decline, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Manganese-based MRI contrast agent may be safer alternative to gadolinium-based agents

November 15, 2017
A team of Massachusetts General Hospital (MGH) researchers has developed a potential alternative to gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI). In their report that has been published online ...

Team finds direct evidence of gadolinium deposition in brain tissues

March 16, 2015
Mayo Clinic research finds direct evidence of gadolinium deposition in neuronal tissues following intravenous administration of gadolinium-based contrast agents used in MRI exams. The findings were recently published online ...

Study: Intracranial pathology not necessary for gadolinium deposition in brain tissues

June 27, 2017
Minute traces of gadolinium, the contrast agent used to enhance MR images, are often retained in the brain tissue of patients years after undergoing MRI. Some studies have suggested this deposition was limited to patients ...

Recommended for you

Licence to Swill: James Bond's drinking over six decades

December 10, 2018
He may be licensed to kill but fictional British secret service agent James Bond has a severe alcohol use disorder, according to an analysis of his drinking behaviour published in the Medical Journal of Australia's Christmas ...

Obesity, risk of cognitive dysfunction? Consider high-intensity interval exercise

December 10, 2018
It's fast-paced, takes less time to do, and burns a lot of calories. High-intensity interval exercise is widely recognized as the most time-efficient and effective way to exercise. In a first-of-its-kind study, researchers ...

How to survive on 'Game of Thrones': Switch allegiances

December 9, 2018
Characters in the Game of Thrones TV series are more likely to die if they do not switch allegiance, and are male, according to an article published in the open access journal Injury Epidemiology.

Expert calls for strong, sustainable action to make world roadways safer

December 7, 2018
According to the latest World Health Organization (WHO) report on road safety, more than 1.3 million people die on the world's roadways each year—and millions more are injured or disabled. Yet despite the huge cost to families ...

Hazelnuts improve older adults' micronutrient levels

December 6, 2018
Older adults who added hazelnuts to their diet for a few months significantly improved their levels of two key micronutrients, new research at Oregon State University indicates.

Regular bedtimes and sufficient sleep for children may lead to healthier teens

December 6, 2018
Having a regular, age-appropriate bedtime and getting sufficient sleep from early childhood may be important for healthy body weight in adolescence, according to researchers at Penn State.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.